White Pine Investment Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Buy
1,315
+112
+9% +$24.1K 0.07% 62
2026
Q1
$262K Sell
1,203
-326
-21% -$72.3K 0.06% 62
2025
Q4
$349K Hold
1,529
0.08% 58
2025
Q3
$354K Buy
1,529
+7
+0.5% +$1.43K 0.08% 59
2025
Q2
$283K Hold
1,522
0.07% 57
2025
Q1
$319K Hold
1,522
0.09% 56
2024
Q4
$270K Hold
1,522
0.07% 61
2024
Q3
$301K Hold
1,522
0.08% 59
2024
Q2
$261K Sell
1,522
-137
-8% -$22.7K 0.08% 58
2024
Q1
$302K Sell
1,659
-50
-3% -$8.62K 0.09% 58
2023
Q4
$265K Hold
1,709
0.09% 59
2023
Q3
$255K Hold
1,709
0.09% 59
2023
Q2
$230K Hold
1,709
0.08% 59
2023
Q1
$272K Hold
1,709
0.1% 59
2022
Q4
$276K Buy
1,709
+117
+7% +$17.9K 0.11% 59
2022
Q3
$214K Hold
1,592
0.09% 61
2022
Q2
$244K Hold
1,592
0.1% 56
2022
Q1
$258K Hold
1,592
0.09% 54
2021
Q4
$216K Buy
+1,592
New +$188K 0.07% 56
2020
Q4
Sell
-2,700
Closed -$236K 54
2020
Q3
$236K Hold
2,700
0.11% 51
2020
Q2
$265K Hold
2,700
0.13% 49
2020
Q1
$206K Buy
2,700
+100
+4% +$8.52K 0.12% 51
2019
Q4
$230K Buy
+2,600
New +$216K 0.09% 60

Other funds holding ABBV

White Pine Investment Company's ABBV Position: Q2 2026 in Review

White Pine Investment Company increased its AbbVie (ABBV) stake by 9.3% in Q2 2026, buying an estimated $24.1K and bringing the position to 1,315 shares worth $331K. The position accounts for 0.07% of the portfolio, ranked #62.

White Pine Investment Company first reported a position in ABBV in Q4 2019 and has held it in 23 quarters since. The position peaked at $354K in Q3 2025. 2,495 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • White Pine Investment Company held 1,315 shares of AbbVie worth $331K as of Q2 2026.
  • White Pine Investment Company bought 112 AbbVie shares in Q2 2026, an estimated $24.1K.
  • AbbVie made up 0.07% of White Pine Investment Company's portfolio in Q2 2026, its #62 holding.
  • White Pine Investment Company first reported a position in AbbVie in Q4 2019 and has held it in 23 quarters since.
  • White Pine Investment Company's AbbVie position peaked at $354K in Q3 2025.
  • 2,495 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on White Pine Investment Company's 13F filing for Q2 2026, filed 20 Jul 2026.